Posts

Showing posts with the label Postpartum Depression Drug Market

Postpartum Depression Drugs and Psychotherapy Are Available For Postpartum Depression Treatment

Image
  Postpartum Depression Drug    Postpartum depression is depression that occurs after childbirth. It may have a detrimental effect on the social and cognitive health of spouses, infants, and children. Symptoms of postpartum depression include feelings of hopelessness and sadness, low energy, anxiety, and sleep problems. Treatment for PPD consists of medication, psychotherapy, and lifestyle changes. Some women are prone to PPD but not all cases can be easily diagnosed.   The current standard of care for postpartum depression is psychotherapy and postpartum depression drug . In March 2019, The U.S. Food and Drug Administration approved Zulresso (brexanolone) injection for intravenous use for the treatment of postpartum depression in adult women. Psychotherapy and medication are the main treatment options for PPD. In addition to medication, psychotherapy also aims at improving relationships and role transitions. This type of therapy usually involves 12 sessions and has ...